Search research articles
Contact Us
Filters
Showing results (471-480 of 520) with videos related to
Page
of 52
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
October 20, 2011
Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?
Mateen C Moghbel, Babak Saboury, Sandip Basu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 15, 2011
Evolving role of FDG PET imaging in assessing joint disorders: a systematic review
Kathleen Carey, Babak Saboury, Sandip Basu, et al.
Hellenic Journal of Nuclear Medicine
|
October 30, 2012
Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changes
Anar Aliyev, Babak Saboury, Thomas C Kwee, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 25, 2007
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries
Gonca G Bural, Drew A Torigian, Wichana Chamroonrat, et al.
Advanced Healthcare Materials
|
June 30, 2015
Fabrication of 3D Scaffolds with Precisely Controlled Substrate Modulus and Pore Size by Templated-Fused Deposition Modeling to Direct Osteogenic Differentiation
Ruijing Guo, Sichang Lu, Jonathan M Page, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 3, 2020
Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease
Rahul V Parghane, Vikas Ostwal, Anant Ramaswamy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant <sup>177</sup>Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
Rahul V Parghane, Manish Bhandare, Vikram Chaudhari, et al.
Nuclear Medicine Communications
|
July 8, 2024
Internal dosimetry and biodistribution of indigenously prepared 177 Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximab
Yeshwanth Edamadaka, Rahul V Parghane, Sudeep Sahu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 8, 2020
Examining Absorbed Doses of Indigenously Developed <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy
Kamaldeep, Gaurav Wanage, Sudeep Kumar Sahu, et al.
Molecular Imaging and Biology
|
October 7, 2009
Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept
Gonca G Bural, Drew A Torigian, Anne Burke, et al.
Page
of 52
Search research articles
Search
Showing results (471-480 of 520) with videos related to
Sort By:
Page
of 52
European Journal of Nuclear Medicine and Molecular Imaging
|
October 20, 2011
Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?
Mateen C Moghbel, Babak Saboury, Sandip Basu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 15, 2011
Evolving role of FDG PET imaging in assessing joint disorders: a systematic review
Kathleen Carey, Babak Saboury, Sandip Basu, et al.
Hellenic Journal of Nuclear Medicine
|
October 30, 2012
Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changes
Anar Aliyev, Babak Saboury, Thomas C Kwee, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 25, 2007
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries
Gonca G Bural, Drew A Torigian, Wichana Chamroonrat, et al.
Advanced Healthcare Materials
|
June 30, 2015
Fabrication of 3D Scaffolds with Precisely Controlled Substrate Modulus and Pore Size by Templated-Fused Deposition Modeling to Direct Osteogenic Differentiation
Ruijing Guo, Sichang Lu, Jonathan M Page, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 3, 2020
Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease
Rahul V Parghane, Vikas Ostwal, Anant Ramaswamy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant <sup>177</sup>Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
Rahul V Parghane, Manish Bhandare, Vikram Chaudhari, et al.
Nuclear Medicine Communications
|
July 8, 2024
Internal dosimetry and biodistribution of indigenously prepared 177 Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximab
Yeshwanth Edamadaka, Rahul V Parghane, Sudeep Sahu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 8, 2020
Examining Absorbed Doses of Indigenously Developed <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy
Kamaldeep, Gaurav Wanage, Sudeep Kumar Sahu, et al.
Molecular Imaging and Biology
|
October 7, 2009
Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept
Gonca G Bural, Drew A Torigian, Anne Burke, et al.
Page
of 52